Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-15

FDA Approved: FEBUXOSTAT — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for febuxostat submitted by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

SUPPL AP for FEBUXOSTAT (FEBUXOSTAT)